Viewing Study NCT06239220


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-26 @ 3:30 AM
Study NCT ID: NCT06239220
Status: RECRUITING
Last Update Posted: 2025-08-27
First Post: 2024-01-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: PD-L1 t-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
Sponsor: Glenn J. Hanna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module